{
    "organizations": [],
    "uuid": "4b7e08493318a586a29e84b44f459e52962a9892",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-madrigal-announces-acceptance-of-m/brief-madrigal-announces-acceptance-of-mgl-3196-abstract-for-a-main-plenary-presentation-idUSFWN1PP10W",
    "ord_in_thread": 0,
    "title": "BRIEF-Madrigal Announces Acceptance Of MGL-3196 Abstract For A Main Plenary Presentation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Madrigal Pharmaceuticals Inc:\n* MADRIGAL ANNOUNCES ACCEPTANCE OF MGL-3196 ABSTRACT FOR A MAIN PLENARY PRESENTATION AT THE INTERNATIONAL LIVER CONGRESSâ„¢ 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T20:03:00.000+02:00",
    "crawled": "2018-01-31T16:52:05.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "madrigal",
        "pharmaceutical",
        "inc",
        "madrigal",
        "announces",
        "acceptance",
        "abstract",
        "main",
        "plenary",
        "presentation",
        "international",
        "liver",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}